Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus
暂无分享,去创建一个
Peter Kruzliak | P. Kruzliak | L. Rodrigo | L. Gašpar | M. Caprnda | D. Mesárošová | P. Ortega | B. Krahulec | E. Egom | I. Mozoș | Ioana Mozos | Martin Caprnda | Dasa Mesarosova | Pablo Fabuel Ortega | Boris Krahulec | Emmanuel Egom | Luis Rodrigo | Ludovit Gaspar | M. Čaprnda | Luis Rodrigo
[1] W. F. Taylor,et al. Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.
[2] I. Hirsch,et al. Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications. , 2010, JAMA.
[3] G. Filippatos,et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2020, European heart journal.
[4] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[5] R. Testa,et al. Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients , 2008, Diabetes.
[6] Z. Li,et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes , 2011, Cardiovascular diabetology.
[7] G. Krishnarajah,et al. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature , 2010, Diabetes, obesity & metabolism.
[8] J. Mastrototaro,et al. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. , 1999, Diabetes research and clinical practice.
[9] E. Kilpatrick,et al. Glycemic Variability: Both Sides of the Story , 2013, Diabetes Care.
[10] L. Norgren,et al. Inter-society consensus for the management of peripheral arterial disease. , 2007, International angiology : a journal of the International Union of Angiology.
[11] G. Paolisso,et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes , 2012, Diabetes Care.
[12] M. Muggeo,et al. Plasma Glucose Levels Throughout the Day and HbA 1 c Interrelationships in Type 2 Diabetes , 2001 .
[13] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[14] G. Paolisso,et al. Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors. , 2013, Atherosclerosis.
[15] L. M. Lou-Arnal,et al. Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients. , 2003, Journal of diabetes and its complications.
[16] A. Rigby,et al. Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT , 2009, Diabetologia.
[17] Pratik Choudhary,et al. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. , 2011, Diabetes technology & therapeutics.
[18] Frits Holleman,et al. Glucose variability; does it matter? , 2010, Endocrine reviews.
[19] S. Tigan,et al. Glycemic Variability and Type 2 Diabetes Mellitus , 2013 .
[20] Jean-Paul Cristol,et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.
[21] D. Owens,et al. Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy , 2009, Diabetologia.
[22] S. Goldstein,et al. A Miniature Fiberoptic pH Sensor Potentially Suitable for Glucose Measurements , 1982, Diabetes Care.
[23] E. Kilpatrick. Arguments for and against the Role of Glucose Variability in the Development of Diabetes Complications , 2009, Journal of diabetes science and technology.
[24] A. Depierre,et al. Harry Potter in True Translation: Long Live the Original , 2014 .
[25] J. DeVries,et al. A Decrease in Glucose Variability Does Not Reduce Cardiovascular Event Rates in Type 2 Diabetic Patients After Acute Myocardial Infarction , 2011, Diabetes Care.
[26] Y. Matsuyama,et al. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up. , 2010, Diabetes research and clinical practice.
[27] M. Ihnat,et al. ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care setting , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[28] R. de Marco,et al. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. , 1997, Circulation.
[29] P. Sönksen,et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.
[30] L. Sestoft. Fructose and the dietary therapy of diabetes mellitus , 1979, Diabetologia.
[31] Zhao Li,et al. Impact of Admission Glycemic Variability, Glucose, and Glycosylated Hemoglobin on Major Adverse Cardiac Events After Acute Myocardial Infarction , 2013, Diabetes Care.
[32] E. Bonora,et al. Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study , 1995, Diabetologia.
[33] B. Kasiske,et al. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Foreword , 2013 .
[34] L. Monnier,et al. Glycemic Variability , 2008, Diabetes Care.
[35] D. Trence,et al. Glycemic Variability: Looking Beyond the A1C , 2012, Diabetes Spectrum.
[36] Chia-Ing Li,et al. Variation of fasting plasma glucose: a predictor of mortality in patients with type 2 diabetes. , 2012, The American journal of medicine.
[37] A. Rigby,et al. Effect of Glucose Variability on the Long-Term Risk of Microvascular Complications in Type 1 Diabetes , 2009, Diabetes Care.
[38] J. DeVries,et al. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes , 2007, Diabetologia.
[39] Paola Palazzo,et al. Impact of Glycemic and Blood Pressure Variability on Surrogate Measures of Cardiovascular Outcomes in Type 2 Diabetic Patients , 2011, Diabetes Care.
[40] P. Valensi,et al. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study. , 2012, Diabetes & metabolism.
[41] Mathias M. Müller,et al. Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement , 2007, Diabetes Care.
[42] E. Bonora,et al. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[43] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.